Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Net sales	$ 29,837	$ 25,752	$ 35,129
Cost of sales	23,600	20,581	28,726
Gross profit	6,237	5,171	6,403
Operating expenses:
Research and development	368	(515)	(202)
Sales and marketing	5,696	6,200	6,415
General and administrative	4,646	5,062	6,115
Loss on impairment	672		156
Valuation of equity instruments		56	1,812
Change in estimate of contingent liabilities	(102)	(411)
Restructuring			26
Total operating expenses	11,280	10,392	14,322
Loss from operations	(5,043)	(5,221)	(7,919)
Other income (expense):
Interest income	2	4	6
Interest expense	(511)	(861)	(573)
Other income (expense)	(157)	21	(25)
Loss before income taxes	(5,709)	(6,057)	(8,511)
Benefit from (provision for) income taxes		2	(6)
Net loss	$ (5,709)	$ (6,055)	$ (8,517)
Net loss per share - basic and diluted (in Dollars per share)	$ (0.14)	$ (0.25)	$ (0.37)
Shares used in computing net loss per share - basic and diluted (in Shares)	41,322	24,669	22,791